Eli Lilly News
Latest articles and news about Eli Lilly on AXL Media.
Latest Articles
- Pharmaceutical Peak Body Slams "Broken" PBS System as Mounjaro Subsidy Stalls
Published: Apr 28, 2026
Section: Medical News
Medicines Australia has labeled the nation's drug subsidy process "broken" after negotiations to list the diabetes medication Mounjaro on the Pharmaceutical Benefits Scheme (PBS) c...
- Harbor Health Care and Valkyrie Bitcoin Miners ETFs Lead Market Momentum in April 2026
Published: Apr 18, 2026
Section: Markets
Strong analyst backing and sector-specific catalysts have positioned the Harbor Health Care (MEDI) and Valkyrie Bitcoin Miners (WGMI) ETFs as top investment choices this month. Whi...
- A Potential Catalyst in Eli Lilly’s 150-Year History
Published: Apr 18, 2026
Section: Companies & Industry
Eli Lilly, a titan in the pharmaceutical industry for a century and a half, is navigating a pivotal moment with the recent launch of Foundayo, an oral GLP-1 treatment. The company,...
- Amazon Pharmacy Integrates Eli Lilly’s Foundayo Weight-Loss Pill into Same-Day Kiosk Network
Published: Apr 10, 2026
Section: Science & Tech
Amazon.com announced on Thursday that its pharmacy division will stock Eli Lilly’s newly approved oral weight-loss medication, Foundayo, at automated kiosks and offer same-day deli...
- United Arab Emirates Approves Eli Lilly Weight Loss Pill for May 2026 Launch Following Successful Clinical Trials
Published: Apr 4, 2026
Section: Middle East
The United Arab Emirates Ministry of Health and Prevention has officially registered orforglipron, an oral weight management medication developed by Eli Lilly, making the UAE the s...
- Major UK Study Reveals 71% Higher Mortality and Cardiovascular Risk for Sleep Apnea Patients
Published: Apr 3, 2026
Section: Medical News
New research involving 2.9 million electronic health records indicates that individuals with obstructive sleep apnea (OSA) face a nearly double risk of cardiovascular events or dea...
- FDA Grants Approval for High-Dose Wegovy as Novo Nordisk Battles Eli Lilly for Weight-Loss Dominance
Published: Apr 2, 2026
Section: Science & Tech
The Food and Drug Administration has approved a 7.2-milligram dose of Novo Nordisk’s weight-loss injection, Wegovy, aimed at closing the efficacy gap with rival medications. Clinic...
- FDA Approves Eli Lilly’s Weight-Loss Pill Foundayo, Intensifying Rivalry with Novo Nordisk
Published: Apr 2, 2026
Section: Medical News
The U.S. Food and Drug Administration has granted approval to Eli Lilly’s oral weight-loss medication, orforglipron, to be marketed as Foundayo. The once-daily pill demonstrated a...
- UK Drug Watchdog Backs Novo Nordisk's Wegovy for Heart Disease Prevention via NHS
Published: Apr 1, 2026
Section: Companies & Industry
The National Institute for Health and Care Excellence (NICE) has recommended Wegovy for reducing the risk of heart attacks and strokes in obese adults. This landmark decision allow...
- Clinical Study Finds Switching to Tirzepatide Significantly Enhances Emotional Well-Being and Quality of Life for Type 2 Diabetes Patients
Published: Mar 31, 2026
Section: Science & Tech
A new analysis from the SURPASS-SWITCH trial reveals that patients transitioning from dulaglutide to tirzepatide experience superior emotional and physical health outcomes alongsid...
- Pharmaceutical Leaders Pivot Toward Oral Weight Loss Solutions in $100 Billion Market
Published: Feb 17, 2026
Section: Medical News
Global pharmaceutical giants, including Novo Nordisk and Eli Lilly, are aggressively developing oral alternatives to blockbuster injectable weight-loss drugs. These pills aim to re...